MFDS — authorised 28 May 2021
- Marketing authorisation holder: AMGEN INC
- Status: likely_approved
🇰🇷 Lumakras in South Korea
MFDS authorised Lumakras on 28 May 2021
Marketing authorisation
Lumakras in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Lumakras approved in South Korea?
Yes. MFDS authorised it on 28 May 2021.
Who is the marketing authorisation holder for Lumakras in South Korea?
AMGEN INC holds the South Korean marketing authorisation.